“…JAs also increased the life span of T-cell lymphoma-bearing mice [17]. Thereafter JAs, including MJ and related synthetic analogs, were found to inhibit in vitro cancer cell proliferation and to induce cell death in other human and murine cancer cell types [16, 19–24], including human breast [15, 25], cervix [26–29], colon [30, 31], colorectal [32], gastric [33], hepatoma [34, 35], lung [19, 36, 37], lymphoma [15, 17, 18, 38], melanoma [15, 30, 39, 40], myeloid leukemia [41, 42], neuroblastoma [43–45], prostate [15, 46–48], and sarcoma [49] cancer cells (Table 1). Other results have shown that JAs and their synthetic derivates exerted selected cytotoxic effects in vivo towards metastatic melanoma [21, 39] and inhibited angiogenesis at high doses (it was the reverse at low doses) in the chorioallantoic membrane (CAM) of chicken embryo [40] (Table 2).…”